MARTINELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 2.992
EU - Europa 1.452
AS - Asia 252
OC - Oceania 10
SA - Sud America 7
AF - Africa 1
Totale 4.714
Nazione #
US - Stati Uniti d'America 2.979
GB - Regno Unito 622
IT - Italia 260
SE - Svezia 153
DE - Germania 149
CN - Cina 93
HK - Hong Kong 69
UA - Ucraina 69
TR - Turchia 44
FI - Finlandia 42
BE - Belgio 34
FR - Francia 28
BG - Bulgaria 27
IE - Irlanda 25
RU - Federazione Russa 18
SG - Singapore 16
VN - Vietnam 13
AU - Australia 10
CA - Canada 9
RO - Romania 7
ES - Italia 5
IN - India 5
JP - Giappone 5
NL - Olanda 5
BZ - Belize 4
AR - Argentina 3
BR - Brasile 3
MY - Malesia 3
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
AM - Armenia 1
AT - Austria 1
CL - Cile 1
DZ - Algeria 1
ID - Indonesia 1
IR - Iran 1
MK - Macedonia 1
PK - Pakistan 1
Totale 4.714
Città #
Southend 522
Fairfield 475
Woodbridge 288
Ashburn 251
Houston 238
Chandler 236
Seattle 192
Ann Arbor 176
Cambridge 172
Wilmington 146
Nyköping 123
Dearborn 122
Jacksonville 119
Modena 83
Hong Kong 69
Fremont 40
New York 40
Brussels 34
Beijing 33
Izmir 29
Princeton 28
Sofia 27
Eugene 26
Bremen 25
Dublin 25
San Diego 25
Helsinki 20
London 20
Milan 20
Rome 14
Dong Ket 12
San Jose 12
Bologna 10
Redwood City 9
Boardman 8
Des Moines 8
Hefei 7
Shanghai 7
Castelnuovo Rangone 6
Falls Church 6
Chicago 5
Perugia 5
San Giuliano Milanese 5
Atlanta 4
Belize City 4
Jinan 4
Kunming 4
Phoenix 4
Saint Petersburg 4
Toronto 4
Verona 4
Barcelona 3
Civitanova Marche 3
Dongguan 3
Guangzhou 3
Kilburn 3
Norwalk 3
Perth 3
Shenyang 3
Sydney 3
São Paulo 3
Wandsworth 3
Albuquerque 2
Amsterdam 2
Ancona 2
Brighton 2
Brisbane 2
Buenos Aires 2
Cava de' Tirreni 2
Changsha 2
Chiswick 2
Clearwater 2
Constanta 2
Dallas 2
Fasano 2
Freiburg 2
Fukushima 2
Fuzhou 2
Gelsenkirchen 2
Genoa 2
Indiana 2
Lappeenranta 2
Las Vegas 2
Los Angeles 2
Martina Franca 2
Montréal 2
Munich 2
Naples 2
Ottawa 2
Parma 2
Saint Louis 2
San Francisco 2
Southwark 2
Timisoara 2
Tokushima 2
Trento 2
Treviso 2
Zagreb 2
Baotou 1
Berlin 1
Totale 3.857
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 405
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 273
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 236
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 223
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 219
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 203
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 201
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 196
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 184
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 184
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 182
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 180
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 180
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 179
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 169
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 167
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 167
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 164
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 164
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 163
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 161
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 147
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 125
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 125
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 107
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 70
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 9
Totale 4.783
Categoria #
all - tutte 15.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019350 0 0 0 0 0 0 0 0 13 50 135 152
2019/20201.115 77 41 25 64 114 171 204 142 105 54 76 42
2020/2021990 83 52 75 119 180 76 79 84 45 87 51 59
2021/2022572 44 68 51 25 6 56 23 25 55 45 119 55
2022/2023730 72 90 55 64 94 95 13 81 92 7 30 37
2023/2024383 20 24 29 58 77 46 51 64 14 0 0 0
Totale 4.783